HNRNPA2B1 and amyotrophic lateral sclerosis: On the other hand, in ALS cases the reported change in hnRNPA2B1 was an aspartate substitution affecting the IDD13 thus showing the deleterious impact of the Aspartate substitutions on disordered domains and their pleiotropic expression.